Table 3.

Comparison of prognosis of the two groups (±SD; n, %).

Group	Control group (n=19)	Observation group (n=21)	t/χ2	p
Activity scores
CDAI	5.29±2.48	3.86±2.16	2.0587	0.0233
UCAI	8.54±3.28	5.38±2.76	3.4889	0.0006
Recurrence rate	6 (31.58)	1 (4.76)	3.2848	0.0395
Adverse reaction			0.8087	0.3284
Nausea	3 (15.79)	3 (14.29)
Emesis	2 (10.53)	1 (4.76)
Others	4 (21.05)	2 (9.52)

CDAI: Crohn’s disease activity index; UCAI, ulcerative colitis activity index.